- Report
- October 2024
- 187 Pages
Global
From €3312EUR$3,545USD£2,802GBP
€3680EUR$3,939USD£3,113GBP
- Report
- April 2025
- 55 Pages
Global
From €2616EUR$2,800USD£2,213GBP
- Report
- April 2025
- 50 Pages
Global
From €2476EUR$2,650USD£2,094GBP
Dydrogesterone is a synthetic progestogen used in the treatment of sexual and reproductive health conditions. It is used to treat a variety of conditions, including endometriosis, premenstrual syndrome, and infertility. It is also used to support pregnancy and to prevent miscarriage. Dydrogesterone is available in both oral and injectable forms. It is generally well tolerated, with few side effects.
Dydrogesterone is used in combination with other drugs to treat a variety of sexual and reproductive health conditions. It is often used in combination with estrogens to treat endometriosis and premenstrual syndrome. It is also used in combination with other drugs to treat infertility and to support pregnancy.
The market for dydrogesterone is growing, driven by increasing awareness of sexual and reproductive health conditions and the need for effective treatments. The market is expected to continue to grow in the coming years.
Some companies in the dydrogesterone market include Mylan, Sun Pharmaceuticals, Lupin, and Cipla. Show Less Read more